1 Study Coverage 1.1 Statins Product Introduction 1.2 Global Statins Outlook 2017 VS 2022 VS 2028 1.2.1 Global Statins Sales in US$ Million for the Year 2017-2028 1.2.2 Global Statins Sales in Volume for the Year 2017-2028 1.3 United States Statins Outlook 2017 VS 2022 VS 2028 1.3.1 United States Statins Sales in US$ Million for the Year 2017-2028 1.3.2 United States Statins Sales in Volume for the Year 2017-2028 1.4 Statins Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4.1 The Market Share of United States Statins in Global, 2017 VS 2022 VS 2028 1.4.2 The Growth Rate of Statins Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.5 Statins Market Dynamics 1.5.1 Statins Industry Trends 1.5.2 Statins Market Drivers 1.5.3 Statins Market Challenges 1.5.4 Statins Market Restraints 1.6 Study Objectives 1.7 Years Considered 2 Market by Type 2.1 Statins Market Segment by Type 2.1.1 Astrovastatin 2.1.2 Fluvastatin 2.1.3 Lovastatin 2.1.4 Pravastatin 2.1.5 Simvastatin 2.1.6 Others 2.2 Global Statins Market Size by Type 2.2.1 Global Statins Sales in Value, by Type (2017, 2022 & 2028) 2.2.2 Global Statins Sales in Volume, by Type (2017, 2022 & 2028) 2.2.3 Global Statins Average Selling Price (ASP) by Type (2017, 2022 & 2028) 2.3 United States Statins Market Size by Type 2.3.1 United States Statins Sales in Value, by Type (2017, 2022 & 2028) 2.3.2 United States Statins Sales in Volume, by Type (2017, 2022 & 2028) 2.3.3 United States Statins Average Selling Price (ASP) by Type (2017, 2022 & 2028) 3 Market by Application 3.1 Statins Market Segment by Application 3.1.1 Hospitals 3.1.2 Clinics 3.2 Global Statins Market Size by Application 3.2.1 Global Statins Sales in Value, by Application (2017, 2022 & 2028) 3.2.2 Global Statins Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 Global Statins Average Selling Price (ASP) by Application (2017, 2022 & 2028) 3.3 United States Statins Market Size by Application 3.3.1 United States Statins Sales in Value, by Application (2017, 2022 & 2028) 3.3.2 United States Statins Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 United States Statins Average Selling Price (ASP) by Application (2017, 2022 & 2028) 4 Global Statins Competitor Landscape by Company 4.1 Global Statins Market Size by Company 4.1.1 Top Global Statins Manufacturers Ranked by Revenue (2021) 4.1.2 Global Statins Revenue by Manufacturer (2017-2022) 4.1.3 Global Statins Sales by Manufacturer (2017-2022) 4.1.4 Global Statins Price by Manufacturer (2017-2022) 4.2 Global Statins Concentration Ratio (CR) 4.2.1 Statins Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Statins in 2021 4.2.3 Global Statins Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Statins Manufacturing Base Distribution, Product Type 4.3.1 Global Statins Manufacturers, Headquarters and Distribution of Producing Region 4.3.2 Manufacturers Statins Product Type 4.3.3 Date of International Manufacturers Enter into Statins Market 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans 4.5 United States Statins Market Size by Company 4.5.1 Top Statins Players in United States, Ranked by Revenue (2021) 4.5.2 United States Statins Revenue by Players (2020, 2021 & 2022) 4.5.3 United States Statins Sales by Players (2020, 2021 & 2022) 5 Global Statins Market Size by Region 5.1 Global Statins Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Statins Market Size in Volume by Region (2017-2028) 5.2.1 Global Statins Sales in Volume by Region: 2017-2022 5.2.2 Global Statins Sales in Volume Forecast by Region (2023-2028) 5.3 Global Statins Market Size in Value by Region (2017-2028) 5.3.1 Global Statins Sales in Value by Region: 2017-2022 5.3.2 Global Statins Sales in Value by Region: 2023-2028 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Statins Market Size YoY Growth 2017-2028 6.1.2 North America Statins Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Statins Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Statins Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Statins Market Size YoY Growth 2017-2028 6.3.2 Europe Statins Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Statins Market Size YoY Growth 2017-2028 6.4.2 Latin America Statins Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Statins Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Statins Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 UAE 7 Company Profiles 7.1 AstraZeneca 7.1.1 AstraZeneca Corporation Information 7.1.2 AstraZeneca Description and Business Overview 7.1.3 AstraZeneca Statins Sales, Revenue and Gross Margin (2017-2022) 7.1.4 AstraZeneca Statins Products Offered 7.1.5 AstraZeneca Recent Development 7.2 Pfizer 7.2.1 Pfizer Corporation Information 7.2.2 Pfizer Description and Business Overview 7.2.3 Pfizer Statins Sales, Revenue and Gross Margin (2017-2022) 7.2.4 Pfizer Statins Products Offered 7.2.5 Pfizer Recent Development 7.3 GlaxoSmithKline 7.3.1 GlaxoSmithKline Corporation Information 7.3.2 GlaxoSmithKline Description and Business Overview 7.3.3 GlaxoSmithKline Statins Sales, Revenue and Gross Margin (2017-2022) 7.3.4 GlaxoSmithKline Statins Products Offered 7.3.5 GlaxoSmithKline Recent Development 7.4 Novartis International 7.4.1 Novartis International Corporation Information 7.4.2 Novartis International Description and Business Overview 7.4.3 Novartis International Statins Sales, Revenue and Gross Margin (2017-2022) 7.4.4 Novartis International Statins Products Offered 7.4.5 Novartis International Recent Development 7.5 Merck 7.5.1 Merck Corporation Information 7.5.2 Merck Description and Business Overview 7.5.3 Merck Statins Sales, Revenue and Gross Margin (2017-2022) 7.5.4 Merck Statins Products Offered 7.5.5 Merck Recent Development 7.6 Biocon 7.6.1 Biocon Corporation Information 7.6.2 Biocon Description and Business Overview 7.6.3 Biocon Statins Sales, Revenue and Gross Margin (2017-2022) 7.6.4 Biocon Statins Products Offered 7.6.5 Biocon Recent Development 7.7 Concord Biotech 7.7.1 Concord Biotech Corporation Information 7.7.2 Concord Biotech Description and Business Overview 7.7.3 Concord Biotech Statins Sales, Revenue and Gross Margin (2017-2022) 7.7.4 Concord Biotech Statins Products Offered 7.7.5 Concord Biotech Recent Development 7.8 Aurobindo Pharma 7.8.1 Aurobindo Pharma Corporation Information 7.8.2 Aurobindo Pharma Description and Business Overview 7.8.3 Aurobindo Pharma Statins Sales, Revenue and Gross Margin (2017-2022) 7.8.4 Aurobindo Pharma Statins Products Offered 7.8.5 Aurobindo Pharma Recent Development 8 Industry Chain and Sales Channels Analysis 8.1 Statins Industry Chain Analysis 8.2 Statins Key Raw Materials 8.2.1 Key Raw Materials 8.2.2 Statins Distributors 8.3 Statins Production Mode & Process 8.4 Statins Sales and Marketing 8.4.1 Statins Sales Channels 8.4.2 Statins Distributors 8.5 Statins Customers 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer

List of Tables Table 1. Statins CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028 Table 2. Statins Market Trends Table 3. Statins Market Drivers Table 4. Statins Market Challenges Table 5. Statins Market Restraints Table 6. Global Statins Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Statins Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Statins Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Statins Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Statins Manufacturers in Global Market, Ranking by Revenue (2021) Table 11. Global Statins Revenue by Manufacturer, (US$ Million), 2017-2022 Table 12. Global Statins Revenue Share by Manufacturer, 2017-2022 Table 13. Global Statins Sales by Manufacturer, (K Units), 2017-2022 Table 14. Global Statins Sales Share by Manufacturer, 2017-2022 Table 15. Global Statins Price by Manufacturer (2017-2022) & (USD/Unit) Table 16. Global Statins Manufacturers Market Concentration Ratio (CR5 and HHI) Table 17. Global Statins by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Statins as of 2021) Table 18. Top Players of Statins in Global Market, Headquarters and Distribution of Producing Region Table 19. Manufacturers Statins Product Type Table 20. Date of International Manufacturers Enter into Statins Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Top Statins Players in United States Market, Ranking by Revenue (2021) Table 23. United States Statins Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 24. United States Statins Revenue Share by Players, 2020, 2021 & 2022 Table 25. United States Statins Sales by Players, (K Units), 2020, 2021 & 2022 Table 26. United States Statins Sales Share by Players, 2020, 2021 & 2022 Table 27. Global Statins Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 28. Global Statins Sales in Volume by Region (2017-2022) & (K Units) Table 29. Global Statins Sales in Volume Forecast by Region (2023-2028) & (K Units) Table 30. Global Statins Sales in Value by Region (2017-2022) & (US$ Million) Table 31. Global Statins Sales in Value Forecast by Region (2023-2028) & (US$ Million) Table 32. North America Statins Sales in Volume by Country (2017-2028) & (K Units) Table 33. North America Statins Sales in Value by Country (2017-2028) & (US$ Million) Table 34. Asia Pacific Statins Sales in Volume by Region (2017-2028) & (K Units) Table 35. Asia Pacific Statins Sales in Value by Region (2017-2028) & (US$ Million) Table 36. Europe Statins Sales in Volume by Country (2017-2028) & (K Units) Table 37. Europe Statins Sales in Value by Country (2017-2028) & (US$ Million) Table 38. Latin America Statins Sales in Volume by Country (2017-2028) & (K Units) Table 39. Latin Americaa Statins Sales in Value by Country (2017-2028) & (US$ Million) Table 40. Middle East and Africa Statins Sales in Volume by Country (2017-2028) & (K Units) Table 41. Middle East and Africa Statins Sales in Value by Country (2017-2028) & (US$ Million) Table 42. AstraZeneca Corporation Information Table 43. AstraZeneca Description and Business Overview Table 44. AstraZeneca Statins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 45. AstraZeneca Statins Product Table 46. AstraZeneca Recent Development Table 47. Pfizer Corporation Information Table 48. Pfizer Description and Business Overview Table 49. Pfizer Statins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 50. Pfizer Product Table 51. Pfizer Recent Development Table 52. GlaxoSmithKline Corporation Information Table 53. GlaxoSmithKline Description and Business Overview Table 54. GlaxoSmithKline Statins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 55. GlaxoSmithKline Product Table 56. GlaxoSmithKline Recent Development Table 57. Novartis International Corporation Information Table 58. Novartis International Description and Business Overview Table 59. Novartis International Statins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 60. Novartis International Product Table 61. Novartis International Recent Development Table 62. Merck Corporation Information Table 63. Merck Description and Business Overview Table 64. Merck Statins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 65. Merck Product Table 66. Merck Recent Development Table 67. Biocon Corporation Information Table 68. Biocon Description and Business Overview Table 69. Biocon Statins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 70. Biocon Product Table 71. Biocon Recent Development Table 72. Concord Biotech Corporation Information Table 73. Concord Biotech Description and Business Overview Table 74. Concord Biotech Statins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 75. Concord Biotech Product Table 76. Concord Biotech Recent Development Table 77. Aurobindo Pharma Corporation Information Table 78. Aurobindo Pharma Description and Business Overview Table 79. Aurobindo Pharma Statins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 80. Aurobindo Pharma Product Table 81. Aurobindo Pharma Recent Development Table 82. Key Raw Materials Lists Table 83. Raw Materials Key Suppliers Lists Table 84. Statins Customers List Table 85. Statins Distributors List Table 86. Research Programs/Design for This Report Table 87. Key Data Information from Secondary Sources Table 88. Key Data Information from Primary Sources List of Figures Figure 1. Statins Product Picture Figure 2. Global Statins Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Statins Market Size 2017-2028 (US$ Million) Figure 4. Global Statins Sales 2017-2028 (K Units) Figure 5. United States Statins Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 6. United States Statins Market Size 2017-2028 (US$ Million) Figure 7. United States Statins Sales 2017-2028 (K Units) Figure 8. United States Statins Market Share in Global, in Value (US$ Million) 2017-2028 Figure 9. United States Statins Market Share in Global, in Volume (K Units) 2017-2028 Figure 10. Statins Report Years Considered Figure 11. Product Picture of Astrovastatin Figure 12. Product Picture of Fluvastatin Figure 13. Product Picture of Lovastatin Figure 14. Product Picture of Pravastatin Figure 15. Product Picture of Simvastatin Figure 16. Product Picture of Others Figure 17. Global Statins Market Share by Type in 2022 & 2028 Figure 18. Global Statins Sales in Value by Type (2017-2028) & (US$ Million) Figure 19. Global Statins Sales Market Share in Value by Type (2017-2028) Figure 20. Global Statins Sales by Type (2017-2028) & (K Units) Figure 21. Global Statins Sales Market Share in Volume by Type (2017-2028) Figure 22. Global Statins Price by Type (2017-2028) & (USD/Unit) Figure 23. United States Statins Market Share by Type in 2022 & 2028 Figure 24. United States Statins Sales in Value by Type (2017-2028) & (US$ Million) Figure 25. United States Statins Sales Market Share in Value by Type (2017-2028) Figure 26. United States Statins Sales by Type (2017-2028) & (K Units) Figure 27. United States Statins Sales Market Share in Volume by Type (2017-2028) Figure 28. United States Statins Price by Type (2017-2028) & (USD/Unit) Figure 29. Product Picture of Hospitals Figure 30. Product Picture of Clinics Figure 31. Global Statins Market Share by Application in 2022 & 2028 Figure 32. Global Statins Sales in Value by Application (2017-2028) & (US$ Million) Figure 33. Global Statins Sales Market Share in Value by Application (2017-2028) Figure 34. Global Statins Sales by Application (2017-2028) & (K Units) Figure 35. Global Statins Sales Market Share in Volume by Application (2017-2028) Figure 36. Global Statins Price by Application (2017-2028) & (USD/Unit) Figure 37. United States Statins Market Share by Application in 2022 & 2028 Figure 38. United States Statins Sales in Value by Application (2017-2028) & (US$ Million) Figure 39. United States Statins Sales Market Share in Value by Application (2017-2028) Figure 40. United States Statins Sales by Application (2017-2028) & (K Units) Figure 41. United States Statins Sales Market Share in Volume by Application (2017-2028) Figure 42. United States Statins Price by Application (2017-2028) & (USD/Unit) Figure 43. North America Statins Sales in Volume Growth Rate 2017-2028 (K Units) Figure 44. North America Statins Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 45. U.S. Statins Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 46. Canada Statins Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 47. Europe Statins Sales in Volume Growth Rate 2017-2028 (K Units) Figure 48. Europe Statins Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 49. Germany Statins Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 50. France Statins Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 51. U.K. Statins Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 52. Italy Statins Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 53. Russia Statins Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 54. Asia-Pacific Statins Sales in Volume Growth Rate 2017-2028 (K Units) Figure 55. Asia-Pacific Statins Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 56. China Statins Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 57. Japan Statins Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 58. South Korea Statins Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 59. India Statins Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 60. Australia Statins Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 61. Taiwan Statins Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 62. Indonesia Statins Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 63. Thailand Statins Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 64. Malaysia Statins Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 65. Philippines Statins Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 66. Latin America Statins Sales in Volume Growth Rate 2017-2028 (K Units) Figure 67. Latin America Statins Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 68. Mexico Statins Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 69. Brazil Statins Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 70. Argentina Statins Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 71. Middle East & Africa Statins Sales in Volume Growth Rate 2017-2028 (K Units) Figure 72. Middle East & Africa Statins Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 73. Turkey Statins Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 74. Saudi Arabia Statins Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 75. UAE Statins Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 76. Statins Value Chain Figure 77. Statins Production Process Figure 78. Channels of Distribution Figure 79. Distributors Profiles Figure 80. Bottom-up and Top-down Approaches for This Report Figure 81. Data Triangulation Figure 82. Key Executives Interviewed

AstraZeneca Pfizer GlaxoSmithKline Novartis International Merck Biocon Concord Biotech Aurobindo Pharma